Abstract
Introduction Portable electroencephalography (EEG) devices offer the potential for accurate quantification of sleep at home but have not been evaluated in relevant populations.
Methods We assessed the Dreem headband (DHB), and its automated sleep staging algorithm in 62 older adults [Age (mean±SD) 70.5±6.7 years; 12 Alzheimer’s]. The accuracy of sleep measures, epoch-by-epoch staging, and the quality of EEG signals for quantitative EEG (qEEG) analysis was compared to standard polysomnography (PSG) in a sleep laboratory.
Results The DHB algorithm accurately estimated total sleep time (TST) and sleep efficiency (SEFF) with a Symmetric Mean Absolute Percentage Error (SMAPE) <10%. Wake after sleep onset (WASO) and number of awakenings (NAW) were underestimated (WASO: ∼17 minutes; NAW: ∼9 counts) with SMAPE <20%. Sleep onset latency (SOL) was overestimated by ∼30 minutes when using the entire DHB recording period, but it was accurate (Bias: 0.3 minutes) when estimated over the lights-off period. Stage N3 and total non-rapid eye movement (REM) sleep durations were estimated accurately (Bias <20 minutes), while REM sleep was overestimated (∼25 minutes; SMAPE: ∼24%). Epoch-by-epoch sleep/wake classification showed acceptable performance (MCC=0.77±0.17) and 5-stage sleep classification was moderate (MCC=0.54±0.14). After artefact removal, 73% of the recordings were usable for qEEG analysis. Concordance (p<0.001) of EEG band power ranged from moderate to good: slow wave activity r2=0.57; theta r2=0.56; alpha r2=0.65; sigma power r2=0.34.
Conclusion DHB algorithm provides accurate estimates of several sleep measures and qEEG metrics. However, further improvement in REM detection is needed to enhance its utility for research and clinical applications.
Statement of Significance Wearable electroencephalography (EEG) devices such as the Dreem headband (DHB), hold promise for accurate monitoring of sleep at home and improving our understanding of neurodegenerative conditions. This study is important because it provides a comprehensive evaluation of the DHB in older adults, including people living with Alzheimer’s. The DHB automatic sleep staging algorithm demonstrated good concordance with polysomnography for most standard sleep statistics, and epoch-by-epoch sleep/wake classification. A novel aspect of the study is the evaluation of the suitability of the DHB EEG signal for quantitative EEG analysis. Our findings highlight the DHB’s key strengths and provide critical recommendations for improving usability and performance to establish its potential utility for large-scale, objective sleep monitoring in community-dwelling older adults.
Competing Interest Statement
DJD received equipment from Somnofy, and is a consultant to Boehringer-Ingelheim and Danisco Sweeteners OY. The other authors declare no competing financial or non-financial interests.
Clinical Protocols
https://doi.org/10.3390/clockssleep6010010
Funding Statement
This work was primarily supported by the UK Dementia Research Institute, Care Research & Technology Centre at Imperial College, London and the University of Surrey, Guildford, United Kingdom [core award numbers UKDRI-7005, CF2023\7 and UKDRI-7206] which receives its funding from UK DRI Ltd, funded by the UK Medical Research Council, Alzheimers Society and Alzheimers Research UK. In part supported by NIHR Oxford Health Biomedical Research Centre [NIHR 203316].
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Ethics committee of University of Surrey (UEC-2019-065-FHMS) and an NHS ethics committee (22/LO/0694) gave ethical approval for this work. This study is also registered as a clinical study (ISRCTN10509121)
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
The data used in this study are available from the co-author Ciro della Monica upon reasonable request. Contact email: c.dellamonica{at}surrey.ac.uk.